iTeos Therapeutics Inc. (ITOS)

AI Score

Unlock

7.41

0.26 (3.64%)

At close: Apr 24, 2025, 3:59 PM

7.49

1.08%

Pre-market: Apr 25, 2025, 07:43 AM EDT

iTeos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue	35M	23.7M	23.7M	-11.3M	1.29M	66.5M	85.99M	127.7M	267.63M	454.23M	539.01M	497.3M	344.77M	104.27M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	612K	845K	1.07M	958K	655K	648K	627K	631K	811K	748K	545K	543K	489K	326K	326K	126K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	34.39M	22.85M	22.63M	-12.26M	637K	65.85M	85.36M	127.07M	266.82M	453.48M	538.47M	496.75M	344.29M	103.94M	-326K	-126K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-159.53M	-150.34M	-144.82M	-173.28M	-150.98M	-93.45M	-65.37M	-19.42M	126.32M	322.46M	417.07M	384.4M	244.9M	16.44M	-76.49M	-55.69M	-45.24M	-38.53M	-32.71M	-30.17M	-28.05M	-19.81M	-12.12M	-6.12M
Interest Income	30.87M	31.05M	31.08M	31.31M	31.77M	23.93M	19.14M	12.16M	4.4M	4.4M	1.16M	92K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-122.04M	-113.87M	-104.17M	-131.48M	-109.03M	-58.1M	-26.66M	14.85M	148.74M	350.03M	424.43M	389.53M	256.46M	17.52M	-65.58M	-46.38M	-38.09M	-28.53M	-24.73M	-23.18M	-22.34M	-16.99M	-10.1M	-4.4M
Net Income	-134.41M	-121.25M	-108.14M	-135.31M	-112.64M	-61.64M	-28.41M	11.52M	96.65M	261.07M	329.72M	297.64M	214.52M	14.74M	-65.58M	-46.32M	-38.03M	-28.5M	-24.75M	-23.3M	-22.45M	-17.08M	-10.16M	-4.4M
Selling & General & Admin	49.08M	49.64M	50.17M	51.15M	50.37M	49.1M	47.22M	45.26M	43.95M	42.44M	40.45M	44.08M	40.51M	36.64M	32.67M	19.97M	15.34M	11.89M	9.79M	9.49M	8.84M	6.56M	3.86M	1.77M
Research & Development	144.83M	135.09M	129.04M	121.83M	113.2M	110.84M	104.14M	101.86M	97.36M	89.32M	81.49M	68.82M	59.37M	51.2M	43.82M	35.72M	29.9M	26.65M	22.92M	20.68M	19.21M	13.25M	8.25M	4.35M
Other Expenses	2.09M	3.31M	4.08M	4.4M	2.31M	-284K	-1.75M	-2.52M	-3.26M	7.68M	-101K	398K	1.38M	-8.47M	282K	234K	1.22M	2.44M	1.95M	1.4M	934K	-11K	221K	756K
Operating Expenses	193.92M	181.83M	175.26M	167.84M	158.44M	156.33M	148.1M	144.6M	138.04M	128.93M	118.31M	106.89M	89.69M	78.29M	65.87M	46.61M	39.31M	30.98M	26.68M	24.58M	23.27M	16.98M	10.32M	5.16M
Interest Expense	n/a	8.18M	8.18M	8.18M	8.18M	n/a	n/a	n/a	2.02M	2.02M	2.02M	2.02M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	1K	1K	1K	1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	194.53M	182.44M	175.87M	168.14M	158.44M	156.33M	148.1M	144.6M	138.04M	128.93M	118.31M	106.89M	89.69M	78.29M	65.87M	46.61M	39.31M	30.98M	26.68M	24.58M	23.27M	16.98M	10.32M	5.16M
Income Tax Expense	12.38M	7.39M	3.96M	3.83M	3.61M	3.54M	1.75M	3.33M	52.08M	88.96M	94.71M	91.78M	41.82M	2.65M	-126K	-57K	-57K	-26K	11K	119K	119K	87K	58K	n/a
Shares Outstanding (Basic)	40.47M	43.14M	39.7M	35.84M	35.84M	35.78M	35.77M	35.72M	35.61M	37.66M	37.51M	38.14M	35.2M	35.2M	35.12M	34.7M	24.35M	24.26M	31.75M	31.75M	9.91M	9.91M	9.91M	9.91M
Shares Outstanding (Diluted)	40.47M	43.14M	39.7M	35.84M	35.84M	35.78M	35.77M	35.72M	37.88M	37.66M	37.64M	38.14M	37.48M	37.48M	35.12M	35.09M	24.35M	24.35M	31.75M	31.75M	9.91M	9.91M	9.91M	9.91M
EPS (Basic)	-3.38	-3.15	-3	-3.78	-3.15	-1.73	-0.8	0.31	2.57	7.26	9.21	8.31	6.10	0.23	-2.19	-1.67	-1.45	-1.38	-1.64	-1.99	-2.26	-1.72	-1.02	-0.44
EPS (Diluted)	-3.38	-3.15	-3	-3.78	-3.15	-1.76	-0.83	0.28	2.54	6.89	8.72	7.82	5.61	0.11	-2.19	-1.67	-1.45	-1.38	-1.64	-1.99	-2.26	-1.72	-1.02	-0.44
EBITDA	-155.14M	-137.7M	-133.29M	-163.47M	-139.87M	-86.9M	-58.83M	-7.85M	135.24M	337.1M	424.75M	390.02M	257.15M	18.25M	-65.05M	-46.01M	-37.91M	-28.72M	-24.36M	-22.02M	-21.17M	-15.96M	-9.46M	-4.45M
EBIT	-154.33M	-143.47M	-137.71M	-166.39M	-144.76M	-85.12M	-57.39M	-7.8M	137.6M	339.53M	426.28M	391.61M	256.28M	17.33M	-65.87M	-46.61M	-39.31M	-30.04M	-25.75M	-23.65M	-22.34M	-16.98M	-10.32M	-5.16M
Depreciation & Amortization	1.24M	1.15M	1.07M	958K	877K	870K	849K	853K	811K	748K	745K	743K	689K	669K	611K	540K	535K	538K	554K	583K	611K	465K	307K	149K